Back
Vanda Pharmaceuticals Vs. Edgewise Therapeutics Industry Stock Comparison
Buy
55
VNDA
Vanda Pharmaceuticals
Last Price:
5.10
Seasonality Move:
4.48%
Buy
58
EWTX
Edgewise Therapeutics
Last Price:
32.86
Seasonality Move:
66.43%
Buy
55
Vanda Pharmaceuticals (VNDA)
is a Buy
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
- The current Vanda Pharmaceuticals [VNDA] share price is $5.10. The Score for VNDA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- VNDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $32.87. The Score for EWTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $5.10
The current trend is moderately bullish and VNDA is experiencing selling pressure, which indicates risk of future bearish movement.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $32.87
The current trend is moderately bearish and EWTX is experiencing slight selling pressure.
VNDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 55.48 | Buy |
| Chaikin Money Flow: | -713389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.56 - 5.12) | Buy |
| Bollinger Bands (100): | (4.68 - 5.7) | Sell |
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 49.08 | Sell |
| Chaikin Money Flow: | -211632 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.74 - 35.72) | Sell |
| Bollinger Bands (100): | (17.09 - 30.81) | Buy |
VNDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.15 | Sell |
| 20-day SMA: | 4.88 | Buy |
| 50-day SMA: | 4.81 | Buy |
| 200-day SMA: | 4.94 | Buy |
| 8-day EMA: | 5.16 | Sell |
| 20-day EMA: | 4.97 | Buy |
| 50-day EMA: | 4.93 | Buy |
| 200-day EMA: | 5.05 | Buy |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.13 | Sell |
| 20-day SMA: | 34.7 | Sell |
| 50-day SMA: | 28.88 | Buy |
| 200-day SMA: | 20.72 | Buy |
| 8-day EMA: | 34.41 | Sell |
| 20-day EMA: | 33.8 | Sell |
| 50-day EMA: | 30.01 | Buy |
| 200-day EMA: | 21.42 | Buy |
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.35 per share.
Vanda Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edgewise Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||